tiprankstipranks
Trending News
More News >
Johnson & Johnson (JNJ)
:JNJ
US Market

Johnson & Johnson (JNJ) Stock Forecast & Price Target

Compare
26,422 Followers
See the Price Targets and Ratings of:

JNJ Analyst Ratings

Moderate Buy
15Ratings
Moderate Buy
7 Buy
8 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Johnson
& Johnson
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

JNJ Stock 12 Month Forecast

Average Price Target

$170.53
▲(11.30%Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is $170.53 with a high forecast of $185.00 and a low forecast of $153.00. The average price target represents a 11.30% change from the last price of $153.22.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"140":"$140","163":"$163","186":"$186","151.5":"$151.5","174.5":"$174.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$185.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":170.53,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$170.53</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":153,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$153.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[140,151.5,163,174.5,186],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,155.4,157.6769230769231,159.95384615384617,162.23076923076923,164.5076923076923,166.7846153846154,169.06153846153848,171.33846153846153,173.6153846153846,175.8923076923077,178.16923076923078,180.44615384615383,182.72307692307692,{"y":185,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,155.4,156.56384615384616,157.7276923076923,158.89153846153846,160.0553846153846,161.21923076923076,162.3830769230769,163.5469230769231,164.71076923076924,165.8746153846154,167.03846153846155,168.2023076923077,169.36615384615385,{"y":170.53,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,155.4,155.2153846153846,155.03076923076924,154.84615384615384,154.66153846153847,154.47692307692307,154.2923076923077,154.1076923076923,153.92307692307693,153.73846153846154,153.55384615384617,153.36923076923077,153.1846153846154,{"y":153,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":142.04,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":141.82,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.69,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":161.84,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.07,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.25,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.26,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.66,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.62,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.95,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.15,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$185.00Average Price Target$170.53Lowest Price Target$153.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JNJ
TipRanks AITipRanks
Not Ranked
TipRanks
$173
Buy
12.91%
Upside
Reiterated
06/05/25
Johnson & Johnson's strong financial performance and positive earnings call are significant strengths, supported by strategic investments and growth in key segments. However, technical indicators show limited momentum, and recent corporate events pose some risks.
RBC Capital
$181
Buy
18.13%
Upside
Reiterated
06/05/25
Johnson & Johnson (JNJ) Gets a Buy from RBC Capital
Morgan Stanley Analyst forecast on JNJ
Terence FlynnMorgan Stanley
Morgan Stanley
$169
Hold
10.30%
Upside
Reiterated
06/04/25
Cautious Hold Rating for Johnson & Johnson Amid Promising Oncology Advances and Competitive Challenges
DBS
$160
Hold
4.43%
Upside
Reiterated
05/30/25
Johnson & Johnson: Hold Rating Amid Stelara Patent Expiry and Strategic Acquisition
Citi
$185
Buy
20.74%
Upside
Assigned
05/22/25
Johnson & Johnson (JNJ) Gets a Buy from Citi
Leerink Partners Analyst forecast on JNJ
David RisingerLeerink Partners
Leerink Partners
$169$153
Hold
-0.14%
Downside
Downgraded
05/15/25
Johnson & Johnson downgraded to Market Perform from Outperform at LeerinkJohnson & Johnson downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on JNJ
Tim AndersonBank of America Securities
Bank of America Securities
$161
Hold
5.08%
Upside
Reiterated
05/14/25
Johnson & Johnson (JNJ) Receives a Hold from Bank of America Securities
Goldman Sachs Analyst forecast on JNJ
Asad HaiderGoldman Sachs
Goldman Sachs
$176
Buy
14.87%
Upside
Reiterated
05/13/25
Johnson & Johnson's Strong Market Position and Growth Potential Highlighted by Tremfya's Success in IBD Market
Barclays Analyst forecast on JNJ
Matt MiksicBarclays
Barclays
$165
Hold
7.69%
Upside
Reiterated
04/29/25
Barclays Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)
TD Cowen
$185
Buy
20.74%
Upside
Reiterated
04/28/25
Johnson & Johnson's Strategic Advancements in Electrophysiology: A Buy Rating by Josh Jennings
HSBC
$180$184
Buy
20.09%
Upside
Reiterated
04/28/25
Johnson & Johnson price target raised to $184 from $180 at HSBCJohnson & Johnson price target raised to $184 from $180 at HSBC
Wells Fargo Analyst forecast on JNJ
Larry BiegelsenWells Fargo
Wells Fargo
$170
Hold
10.95%
Upside
Reiterated
04/27/25
Wells Fargo Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)
UBS
$180
Buy
17.48%
Upside
Reiterated
04/16/25
UBS reiterates Buy Rating on Johnson Johnson (JNJ)UBS analyst Danielle Antalffy reiterated a Buy rating and $180.00 price target on Johnson Johnson (NYSE: JNJ).
Bernstein Analyst forecast on JNJ
Lee HambrightBernstein
Bernstein
$158$159
Hold
3.77%
Upside
Reiterated
04/15/25
Hold Rating for Johnson & Johnson Amid Mixed Outlook and Macroeconomic Challenges
Raymond James Analyst forecast on JNJ
Jayson BedfordRaymond James
Raymond James
$165$164
Buy
7.04%
Upside
Reiterated
04/14/25
Johnson & Johnson price target raised to $164 from $162 at Raymond JamesJohnson & Johnson price target raised to $164 from $162 at Raymond James
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JNJ
TipRanks AITipRanks
Not Ranked
TipRanks
$173
Buy
12.91%
Upside
Reiterated
06/05/25
Johnson & Johnson's strong financial performance and positive earnings call are significant strengths, supported by strategic investments and growth in key segments. However, technical indicators show limited momentum, and recent corporate events pose some risks.
RBC Capital
$181
Buy
18.13%
Upside
Reiterated
06/05/25
Johnson & Johnson (JNJ) Gets a Buy from RBC Capital
Morgan Stanley Analyst forecast on JNJ
Terence FlynnMorgan Stanley
Morgan Stanley
$169
Hold
10.30%
Upside
Reiterated
06/04/25
Cautious Hold Rating for Johnson & Johnson Amid Promising Oncology Advances and Competitive Challenges
DBS
$160
Hold
4.43%
Upside
Reiterated
05/30/25
Johnson & Johnson: Hold Rating Amid Stelara Patent Expiry and Strategic Acquisition
Citi
$185
Buy
20.74%
Upside
Assigned
05/22/25
Johnson & Johnson (JNJ) Gets a Buy from Citi
Leerink Partners Analyst forecast on JNJ
David RisingerLeerink Partners
Leerink Partners
$169$153
Hold
-0.14%
Downside
Downgraded
05/15/25
Johnson & Johnson downgraded to Market Perform from Outperform at LeerinkJohnson & Johnson downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on JNJ
Tim AndersonBank of America Securities
Bank of America Securities
$161
Hold
5.08%
Upside
Reiterated
05/14/25
Johnson & Johnson (JNJ) Receives a Hold from Bank of America Securities
Goldman Sachs Analyst forecast on JNJ
Asad HaiderGoldman Sachs
Goldman Sachs
$176
Buy
14.87%
Upside
Reiterated
05/13/25
Johnson & Johnson's Strong Market Position and Growth Potential Highlighted by Tremfya's Success in IBD Market
Barclays Analyst forecast on JNJ
Matt MiksicBarclays
Barclays
$165
Hold
7.69%
Upside
Reiterated
04/29/25
Barclays Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)
TD Cowen
$185
Buy
20.74%
Upside
Reiterated
04/28/25
Johnson & Johnson's Strategic Advancements in Electrophysiology: A Buy Rating by Josh Jennings
HSBC
$180$184
Buy
20.09%
Upside
Reiterated
04/28/25
Johnson & Johnson price target raised to $184 from $180 at HSBCJohnson & Johnson price target raised to $184 from $180 at HSBC
Wells Fargo Analyst forecast on JNJ
Larry BiegelsenWells Fargo
Wells Fargo
$170
Hold
10.95%
Upside
Reiterated
04/27/25
Wells Fargo Reaffirms Their Hold Rating on Johnson & Johnson (JNJ)
UBS
$180
Buy
17.48%
Upside
Reiterated
04/16/25
UBS reiterates Buy Rating on Johnson Johnson (JNJ)UBS analyst Danielle Antalffy reiterated a Buy rating and $180.00 price target on Johnson Johnson (NYSE: JNJ).
Bernstein Analyst forecast on JNJ
Lee HambrightBernstein
Bernstein
$158$159
Hold
3.77%
Upside
Reiterated
04/15/25
Hold Rating for Johnson & Johnson Amid Mixed Outlook and Macroeconomic Challenges
Raymond James Analyst forecast on JNJ
Jayson BedfordRaymond James
Raymond James
$165$164
Buy
7.04%
Upside
Reiterated
04/14/25
Johnson & Johnson price target raised to $164 from $162 at Raymond JamesJohnson & Johnson price target raised to $164 from $162 at Raymond James
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Johnson & Johnson

1 Month
xxx
Success Rate
14/24 ratings generated profit
58%
Average Return
+0.98%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +0.98% per trade.
3 Months
xxx
Success Rate
21/24 ratings generated profit
88%
Average Return
+3.98%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +3.98% per trade.
1 Year
Success Rate
24/24 ratings generated profit
100%
Average Return
+9.11%
reiterated a buy rating 2 months ago
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +9.11% per trade.
2 Years
xxx
Success Rate
40/45 ratings generated profit
89%
Average Return
+15.92%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +15.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

JNJ Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
13
14
19
23
19
Hold
23
23
22
23
19
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
36
37
41
46
38
In the current month, JNJ has received 19 Buy Ratings, 19 Hold Ratings, and 0 Sell Ratings. JNJ average Analyst price target in the past 3 months is 170.53.
Each month's total comprises the sum of three months' worth of ratings.

JNJ Financial Forecast

JNJ Earnings Forecast

Next quarter’s earnings estimate for JNJ is $2.68 with a range of $2.56 to $2.99. The previous quarter’s EPS was $2.77. JNJ beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.
Next quarter’s earnings estimate for JNJ is $2.68 with a range of $2.56 to $2.99. The previous quarter’s EPS was $2.77. JNJ beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.

JNJ Sales Forecast

Next quarter’s sales forecast for JNJ is $22.84B with a range of $22.51B to $23.09B. The previous quarter’s sales results were $21.89B. JNJ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.
Next quarter’s sales forecast for JNJ is $22.84B with a range of $22.51B to $23.09B. The previous quarter’s sales results were $21.89B. JNJ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year JNJ has Outperformed its overall industry.

JNJ Stock Forecast FAQ

What is JNJ’s average 12-month price target, according to analysts?
Based on analyst ratings, Johnson & Johnson’s 12-month average price target is 170.53.
    What is JNJ’s upside potential, based on the analysts’ average price target?
    Johnson & Johnson has 11.30% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is JNJ a Buy, Sell or Hold?
          Johnson & Johnson has a consensus rating of Moderate Buy which is based on 7 buy ratings, 8 hold ratings and 0 sell ratings.
            What is Johnson & Johnson’s price target?
            The average price target for Johnson & Johnson is 170.53. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $185.00 ,the lowest forecast is $153.00. The average price target represents 11.30% Increase from the current price of $153.22.
              What do analysts say about Johnson & Johnson?
              Johnson & Johnson’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of JNJ?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis